錢祖明, 呂研嫚, 周以和, 李經家, 黃俊農, 柯宏龍, 耿俊閎, 陳思翰, 黃琮懿, 黃書彬
1高雄醫學大學 附設中和紀念醫院 泌尿科
Da Vinci surgery in KMUH urology department – Preliminary results
Tsu-Ming Chien1, Yen-Man Lu1, Yii-Her Chou1,2, Ching-Chia Li1,3, Chun-Nung Huang1,2, Hung-Lung Ke1,2, Jiun-Hung Geng1, Szu-Han Chen1, Tsung-Yi Huang1, Shu-Pin Huang1,2
1Division of Urology,
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
2School of Medicine,
Kaohsiung Medical University, Kaohsiung, Taiwan
3Division of Urology,
Kaohsiung Municipal Ta-Tung Hospital
The U.S. Food and Drug Administration (FDA) first approved the Da Vinci operation system for laparoscopic procedures in 2000, making it the first robotic system allowed in American operating rooms. The system was introduced to Kaohsiung Medical University hospital (KMUH) in March 2013. We reported our preliminary results in urology department.
Materials and Methods:
Between April 2013 and March 2015, there were 70 patients received the Da Vinci operation. Clinical characteristics were collected retrospectively. Operation details and post operation results were also recorded.
There were 56 patients underwent radical prostatectomy, 5 for nephroureterectomy, 2 for adrenalectomy, 2 for partial nephrectomy, 2 for renal cyst unroofing, 1 for nephrectomy, 1 for renal pyeloplasty and 1 for ureterolithotomy. There was no patient with conversion to open operation. The mean operation time for radical prostatectomy was 369.6±97.0 mins, nephroureteroctomy was 366.3±87.2 mins, adrenalectomy for 207.5±45.9 mins, partial nephrectomy was 337.5±24.7 mins, renal cyst unroofing was 207.5±45.9, nephrectomy was 360 mins, renal pyeloplasty was 255 mins and ureterolithotomy was 260 mins, respectively. Post operation incontinence rate and PSA-free survival data will be presented.
Our preliminary data showed an acceptable results with no patient conversion to open operation.